OmniAb News

OmniAb to Report First Quarter 2024 Financial Results on May 9

EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three months ended March 31, 2024 after the close of the U.S. financial markets on Thursday, May

BusinesswireApr 22 08:00 ET

Express News | OmniAb Inc : Leerink Partners Raises Target Price to $13 From $11

Moomoo 24/7Apr 12 08:03 ET

RBC Capital Remains a Buy on OmniAb (OABI)

TipRanksApr 8 21:46 ET

OmniAb Price Target Maintained With a $10.00/Share by Truist Securities

OmniAb Price Target Maintained With a $10.00/Share by Truist Securities

Dow JonesMar 26 09:28 ET

Express News | Truist Securities Maintains Buy on OmniAb, Maintains $10 Price Target

Moomoo 24/7Mar 26 09:18 ET

Over $1M Bet On OmniAb? Check Out These 3 Stocks Insiders Are Buying

Although U.S. stocks closed lower on Monday, there were a few notable insider trades. When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stoc

BenzingaMar 26 08:40 ET

President of OmniAb Matthew Foehr Buys 8.4% More Shares

Those following along with OmniAb, Inc. (NASDAQ:OABI) will no doubt be intrigued by the recent purchase of shares by Matthew Foehr, President of the company, who spent a stonking US$1.2m on stock at a

Simply Wall StMar 26 07:15 ET

OmniAb Inc (OABI) President and CEO Matthew Foehr Acquires 225,000 Shares

Yahoo FinanceMar 25 11:00 ET

Craig-Hallum Sticks to Their Buy Rating for OmniAb (OABI)

TipRanksMar 25 10:25 ET

OmniAb Insider Bought Shares Worth $1,167,750, According to a Recent SEC Filing

Matthew W Foehr, Director, President and CEO, on March 22, 2024, executed a purchase for 225,000 shares in OmniAb (OABI) for $1,167,750. Following the Form 4 filing with the SEC, Foehr has control ove

MT NewswiresMar 25 09:30 ET

OmniAb(OABI.US) Officer Buys US$1.17 Million in Common Stocks

$OmniAb(OABI.US)$ Officer FOEHR MATTHEW W purchased 225K shares of Common Stocks on Mar 22, 2024 at an average price of $5.19 for a total value of $1.17 million.Source: Announcement What is statement

moomoo NewsMar 25 08:00 ET

Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), OmniAb (OABI) and Vericel (VCEL)

TipRanksMar 24 21:40 ET

Express News | Benchmark Reiterates Buy on OmniAb, Maintains $8 Price Target

Moomoo 24/7Mar 22 13:32 ET

Benchmark Co. Reaffirms Their Buy Rating on OmniAb (OABI)

TipRanksMar 22 07:18 ET

OmniAb Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

OmniAb Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

Dow JonesMar 21 11:37 ET

RBC Capital Reiterates Outperform on OmniAb, Maintains $7 Price Target

RBC Capital analyst Conor McNamara reiterates OmniAb (NASDAQ:OABI) with a Outperform and maintains $7 price target.

BenzingaMar 21 11:10 ET

OmniAb Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/21/2024 25.9% RBC Capital → $7 Reiterates Outperform → Outperform 11/14/2023 43.88% Benchmark → $8 Reit

BenzingaMar 21 11:08 ET

OmniAb's Market Potential and Financial Stability Affirm Buy Rating

TipRanksMar 21 10:45 ET

Sector Update: Health Care Stocks Gain Pre-Bell Thursday

Health care stocks were gaining pre-bell Thursday as the Health Care Select Sector SPDR Fund (XLV) was 0.1% higher and the iShares Biotechnology ETF (IBB) was up 0.7% recently. Immatics (IMTX) shares

MT NewswiresMar 21 09:14 ET

Stifel Nicolaus Sticks to Its Buy Rating for OmniAb (OABI)

TipRanksMar 21 07:27 ET